Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUSPENSIONStandard

TRIESENCE

TRIAMCINOLONE ACETONIDE

Standard Dose
40MGML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TRIESENCE is listed in Drugs@FDA under application 022223 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRIAMCINOLONE ACETONIDE Form and strength INJECTABLE; SUSPENSION - 40MGML Sponsor ALCON RES Submission history Latest submission status date: 2007-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIESENCE is listed in Drugs@FDA under application 022223 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRIAMCINOLONE ACETONIDE Form and strength INJECTABLE; SUSPENSION - 40MGML Sponsor ALCON RES Submission history Latest submission status date: 2007-11-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TRIESENCE (TRIAMCINOLONE ACETONIDE) | Drug Monograph | MedicHelpline